Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03036124 |
|---|---|
| Brief Title: | Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure (DAPA-HF) |
| First Submitted : | January 26, 2017 |
| First Submitted that Met QC Criteria : | January 26, 2017 |
| First Posted : | January 30, 2017 (Estimate) |
| Results First Submitted : | July 6, 2020 |
| Results First Posted with QC Comments : | August 18, 2020 |
| Results First Submitted that Met QC Criteria : | August 31, 2020 |
| Results First Posted : | September 1, 2020 |
| Last Update Submitted that Met QC Criteria : | August 31, 2020 |
| Last Update Posted : | September 1, 2020 |